Mismatched unrelated hematopoietic stem cell transplantation with post-transplant cyclophosphamide for high-risk acute myeloid leukemia

Ann Hematol. 2016 May;95(6):1023-5. doi: 10.1007/s00277-016-2652-8. Epub 2016 Apr 8.

Authors

Affiliations

¹ Department of Medicine II, Hematology and Oncology, University Hospital Frankfurt, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.
² Universita' Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Gemelli, Rome, Italy.
³ Department of Medicine II, Hematology and Oncology, University Hospital Frankfurt, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany. [email protected].

PMID: 27056199
DOI: 10.1007/s00277-016-2652-8

No abstract available

Publication types

Letter

MeSH terms

Adult
Cyclophosphamide / administration & dosage*
Female
Graft vs Host Disease / prevention & control
Hematopoietic Stem Cell Transplantation / adverse effects
Hematopoietic Stem Cell Transplantation / methods*
Humans
Immunosuppressive Agents / administration & dosage*
Leukemia, Myeloid, Acute / diagnosis*
Leukemia, Myeloid, Acute / therapy*
Male
Middle Aged
Risk Factors

Substances

Immunosuppressive Agents
Cyclophosphamide